Feasibility of extracorporeal elimination of liposomal chemotherapeutics by double membrane plasmapheresis - CARL-Studie
Phase of Trial: Phase II
Latest Information Update: 06 Sep 2016
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Vinorelbine
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms CARL
- 27 Dec 2012 Planned number of patients changed from 15 to 21 as reported by German Clinical Trials Register.
- 27 Dec 2012 Status changed from active, no longer recruiting to recruiting as reported by German Clinical Trials Register.
- 06 Sep 2011 New trial record